So what comes next
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
These treatments imitate naturally occurring glucagon-like peptide-1 hormones, they help steer blood sugar levels, insulin release, and hunger or appetite control, in a kind of coordinated way
Merck Group One of the world's leading innovators in cancer treatment and vaccine development
Try these tips to help settle your stomach and ease side effects
Tirzepatide addresses the limitations of standalone GIP therapy in diabetes by combining GIPR and GLP-1 receptor (GLP-1R) agonism, leveraging their complementary mechanisms [23]